Zobrazeno 1 - 10
of 1 767
pro vyhledávání: '"Pennell NA"'
Autor:
Muthusamy B; Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH 44195, USA., Berktas M; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Li J; Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA., Thomas DS; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Sun P; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Taylor A; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Pennell NA; Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH 44195, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Jun 25, pp. 1-14. Date of Electronic Publication: 2024 Jun 25.
Autor:
Goldschmidt JH; The US Oncology Network, Blacksburg, VA, USA., Annavarapu S; Ontada, Boston, MA, USA., Venkatasetty D; Ontada, Boston, MA, USA., Wang Y; Ontada, Boston, MA, USA., Santorelli ML; Merck & Co., Inc., Rahway, NJ, USA., Burke T; Merck & Co., Inc., Rahway, NJ, USA., Pennell NA; Cleveland Clinic, Cleveland, OH, USA.
Publikováno v:
Immunotherapy [Immunotherapy] 2024 Apr; Vol. 16 (7), pp. 453-464. Date of Electronic Publication: 2024 Mar 15.
Autor:
West HJ; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California, USA.; AccessHope, Los Angeles, California, USA., Pennell NA; Cleveland Clinic Cancer Institute, Cleveland, Ohio, USA.
Publikováno v:
Cancer [Cancer] 2024 Mar 01; Vol. 130 (5), pp. 659-664. Date of Electronic Publication: 2023 Nov 14.
Autor:
Delasos L; Department of Thoracic Oncology, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Electronic address: delasol@ccf.org., Wei W; Department of Thoracic Oncology, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Hassan KA; Department of Thoracic Oncology, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Pennell NA; Department of Thoracic Oncology, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Patil P; Department of Thoracic Oncology, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Stevenson J; Department of Thoracic Oncology, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2023 Sep; Vol. 24 (6), pp. e205-e213. Date of Electronic Publication: 2023 Apr 23.
Autor:
Muthusamy B; Department of Hematology and Medical Oncology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA., Pennell NA; Department of Hematology and Medical Oncology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA.
Publikováno v:
Translational lung cancer research [Transl Lung Cancer Res] 2023 Jul 31; Vol. 12 (7), pp. 1649-1651. Date of Electronic Publication: 2023 May 22.
Autor:
Somasundaram E; Case Western Reserve University School of Medicine, Cleveland, OH., Wadhwa RR; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH., Litzler A; Department of Applied Mathematics, University of Colorado Boulder, Boulder, CO., Barker-Clarke R; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH., Qi P; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Videtic G; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Stephans K; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Pennell NA; Department of Hematology Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Case Comprehensive Cancer Center, Cleveland, OH., Raymond D; Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH., Yang K; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Kattan MW; Case Comprehensive Cancer Center, Cleveland, OH.; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH., Scott JG; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Case Comprehensive Cancer Center, Cleveland, OH.; Department of Systems Biology and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Jun; Vol. 7, pp. e2200173.
Autor:
Ravi A; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hellmann MD; AstraZeneca, Oncology R&D, New York, NY, USA., Arniella MB; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Holton M; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Freeman SS; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Naranbhai V; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Center for the AIDS Programme for Research in South Africa, Durban, South Africa.; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA., Stewart C; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Leshchiner I; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Kim J; GlaxoSmithKline, Waltham, MA, USA., Akiyama Y; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA., Griffin AT; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA., Vokes NI; Department of Thoracic and Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA., Sakhi M; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA., Kamesan V; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA., Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Forde PM; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Anagnostou V; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Riess JW; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gibbons DL; Department of Thoracic and Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA., Pennell NA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Velcheti V; Department of Hematology and Oncology, NYU Langone Health, New York, NY, USA., Digumarthy SR; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Radiology, Massachusetts General Hospital, Boston, MA, USA., Mino-Kenudson M; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Califano A; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.; Department of Biomedical Informatics, Columbia University, New York, NY, USA.; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.; J.P. Sulzberger Columbia Genome Center, New York, NY, USA., Heymach JV; Department of Thoracic and Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA., Herbst RS; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Brahmer JR; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Schalper KA; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Velculescu VE; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Henick BS; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Rizvi N; Synthekine, Inc., Menlo Park, CA, USA., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Chow A; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Greenbaum BD; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Physiology, Biophysics & Systems Biology, Weill Cornell Medicine, Weill Cornell Medical College, New York, NY, USA., Luksza M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Shaw AT; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA., Wolchok J; Weill Cornell Medicine, New York, NY, USA., Hacohen N; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. nhacohen@broadinstitute.org.; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA. nhacohen@broadinstitute.org.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. nhacohen@broadinstitute.org., Getz G; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org., Gainor JF; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA. jgainor@mgh.harvard.edu.; Center for Thoracic Cancers, Massachusetts General Hospital, Boston, MA, USA. jgainor@mgh.harvard.edu.
Publikováno v:
Nature genetics [Nat Genet] 2023 May; Vol. 55 (5), pp. 807-819. Date of Electronic Publication: 2023 Apr 06.
Autor:
Grivas, P, Khaki, AR, Wise-Draper, TM, French, B, Hennessy, C, Hsu, C-Y, Shyr, Y, Li, X, Choueiri, TK, Painter, CA, Peters, S, Rini, BI, Thompson, MA, Mishra, S, Rivera, DR, Acoba, JD, Abidi, MZ, Bakouny, Z, Bashir, B, Bekaii-Saab, T, Berg, S, Bernicker, EH, Bilen, MA, Bindal, P, Bishnoi, R, Bouganim, N, Bowles, DW, Cabal, A, Caimi, PF, Chism, DD, Crowell, J, Curran, C, Desai, A, Dixon, B, Doroshow, DB, Durbin, EB, Elkrief, A, Farmakiotis, D, Fazio, A, Fecher, LA, Flora, DB, Friese, CR, Fu, J, Gadgeel, SM, Galsky, MD, Gill, DM, Glover, MJ, Goyal, S, Grover, P, Gulati, S, Gupta, S, Halabi, S, Halfdanarson, TR, Halmos, B, Hausrath, DJ, Hawley, JE, Hsu, E, Huynh-Le, M, Hwang, C, Jani, C, Jayaraj, A, Johnson, DB, Kasi, A, Khan, H, Koshkin, VS, Kuderer, NM, Kwon, DH, Lammers, PE, Li, A, Loaiza-Bonilla, A, Low, CA, Lustberg, MB, Lyman, GH, McKay, RR, McNair, C, Menon, H, Mesa, RA, Mico, V, Mundt, D, Nagaraj, G, Nakasone, ES, Nakayama, J, Nizam, A, Nock, NL, Park, C, Patel, JM, Patel, KG, Peddi, P, Pennell, NA, Piper-Vallillo, AJ, Puc, M, Ravindranathan, D, Reeves, ME, Reuben, DY, Rosenstein, L, Rosovsky, RP, Rubinstein, SM, Salazar, M, Schmidt, AL, Schwartz, GK
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology, vol 32, iss 6
BackgroundPatients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::32464797f1049465c364360d3ca626d5
https://escholarship.org/uc/item/49m429m0
https://escholarship.org/uc/item/49m429m0
Autor:
Nagasaka M; University of California Irvine School of Medicine, Orange, CA, USA.; Chao Family Comprehensive Cancer Center, Orange, CA, USA., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China., Choi CM; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Yang N; Department of Medical Oncology, Hunan Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, China., Liu G; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Pérol M; Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France., Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Centre, Villejuif, France; Paris-Saclay University, Orsay, France., Nieva J; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Raez L; Thoracic Oncology Program, Memorial Cancer Institute/Memorial Health Care System, Florida Atlantic University, Miami, FL, USA., Pennell NA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Dimou A; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Marinis F; European Institute of Oncology, IRCCS, Milan, Italy., Ciardiello F; Department of Precision Medicine, Division of Medical Oncology, University of Campania Luigi Vanvitelli, Naples, Italy., Seto T; Precision Medicine Asia (PREMIA) Co. Ltd, Tokyo, Japan., Hu Z; AnHeart Therapeutics, NY, USA., Pan M; AnHeart Therapeutics, NY, USA., Wang W; AnHeart Therapeutics, NY, USA., Li S; AnHeart Therapeutics, NY, USA., Ou SI; University of California Irvine School of Medicine, Orange, CA, USA.; Chao Family Comprehensive Cancer Center, Orange, CA, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2023 Jan; Vol. 19 (2), pp. 123-135. Date of Electronic Publication: 2023 Mar 06.
Autor:
Lemmon CA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Present address: University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Hematology and Oncology, Cincinnati, OH., Zhou J; Cleveland Clinic Lerner Research Institute, Department of Quantitative Health Sciences, Cleveland, OH.; Present address: Department of Neuroscience, Novartis, Cambridge, MA., Hobbs B; Cleveland Clinic Lerner Research Institute, Department of Quantitative Health Sciences, Cleveland, OH.; Present address: Department of Population Health, Dell Medical School, The University of Texas at Austin, Austin, TX., Pennell NA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Jan; Vol. 7, pp. e2200294.